{
    "2018-04-10": [
        [
            {
                "time": "",
                "original_text": "[优于大势评级]医药商业行业深度报告：业绩峰回路转 行业整合加速",
                "features": {
                    "keywords": [
                        "医药商业",
                        "业绩",
                        "行业整合",
                        "加速"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]上海医药(601607)公司跟踪报告：联、合营企业拖累业绩 趋势向好",
                "features": {
                    "keywords": [
                        "上海医药",
                        "联营企业",
                        "拖累业绩",
                        "趋势向好"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "深度挖掘低估值公司的修复行情—以低估值为主的防御型策略",
                "features": {
                    "keywords": [
                        "低估值",
                        "修复行情",
                        "防御型策略"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]零售连锁药店行业定期报告：分级管理和电子处方试点加速处方外流",
                "features": {
                    "keywords": [
                        "零售连锁药店",
                        "分级管理",
                        "电子处方",
                        "处方外流",
                        "加速"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药与健康护理行业专题报告：价值被低估 看多医药商业板块",
                "features": {
                    "keywords": [
                        "医药与健康护理",
                        "价值低估",
                        "看多",
                        "医药商业板块"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "社保基金连续三个季度持仓161只个股 解密布局策略",
                "features": {
                    "keywords": [
                        "社保基金",
                        "持仓",
                        "布局策略"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "上海医药深度报告:商业受两票制影响将减弱,一致性评价推进助力工业发展",
                "features": {
                    "keywords": [
                        "上海医药",
                        "两票制",
                        "影响减弱",
                        "一致性评价",
                        "工业发展"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}